Extracurricular laboratory: Synthetic route of 2834-05-1

There is still a lot of research devoted to this compound(SMILES:O=C(O)CCCCCCCCCCBr)Reference of 11-Bromoundecanoic acid, and with the development of science, more effects of this compound(2834-05-1) can be discovered.

Reference of 11-Bromoundecanoic acid. Aromatic compounds can be divided into two categories: single heterocycles and fused heterocycles. Compound: 11-Bromoundecanoic acid, is researched, Molecular C11H21BrO2, CAS is 2834-05-1, about Expansion of the structure-activity relationship of branched chain fatty acids: Effect of unsaturation and branching group size on anticancer activity. Author is Roy, Ritik; Roseblade, Ariane; Rawling, Tristan.

Branched chain fatty acids (BCFAs) are a class of fatty acid with promising anticancer activity. The BCFA 13-methyltetradecanoic acid (13-MTD) inhibits tumor growth in vivo without toxicity but efficacy is limited by moderate potency, a property shared by all known BCFAs. The mechanism of action of BCFAs has not been fully elucidated, and in the absence of a clearly defined target optimization of BCFA potency must rely on structure-activity relationships. Our current understanding of the structural features that promote BCFA anticancer activity is limited by the low structural diversity of reported BCFAs. The aim of this study was to examine the effects of two new structural modifications- unsaturation and branching group size- on BCFA activity. Thus, homologous series of saturated and cis-Δ11 unsaturated BCFAs were synthesized bearing Me, Et, Pr and Bu branching groups, and were screened in vitro for activity against three human cancer cell lines. Potencies of the new BCFAs were compared to 13-MTD and an unbranched monounstaurated fatty acid (MUFA) bearing a cis-Δ11 double bond. The principal findings to emerge were that the anticancer activity of BCFAs was adversly affected by larger branching groups but significantly improved by incorporation of a cis-Δ11 double bond into the BCFA alkyl chain. This study provides new structure-activity relationship insights that may be used to develop BCFAs with improved potency and therapeutic potential.

There is still a lot of research devoted to this compound(SMILES:O=C(O)CCCCCCCCCCBr)Reference of 11-Bromoundecanoic acid, and with the development of science, more effects of this compound(2834-05-1) can be discovered.

Reference:
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI